Apollomics, Inc. (NASDAQ:APLMW) Sees Large Decline in Short Interest

Apollomics, Inc. (NASDAQ:APLMW) was the recipient of a significant decrease in short interest in February. As of February 28th, there was short interest totalling 3,500 shares, a decrease of 20.5% from the February 13th total of 4,400 shares. Based on an average trading volume of 29,700 shares, the days-to-cover ratio is presently 0.1 days.

Apollomics Stock Performance

Apollomics stock opened at $0.01 on Wednesday. The stock has a fifty day moving average price of $0.01 and a two-hundred day moving average price of $0.01. Apollomics has a 52-week low of $0.01 and a 52-week high of $0.03.

About Apollomics

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.